v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating activities    
Net income (loss) $ (11,208) $ 36,094
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Stock-based compensation expense 1,600 8,235
Depreciation and amortization expense 46 2,067
Change in liability related to sale of future revenues 276 2,700
Amortization (accretion) of investment premiums (discounts) (71) 175
Non-cash operating lease expense 570 4,733
Loss on impairment of lease right-of-use asset   4,130
Gain on derecognition of lease liabilities   (1,167)
Other non-cash items, net 164 551
Changes in operating assets and liabilities:    
Accounts receivable 562 (431)
Inventories   10,655
Other current assets 1,772 5,844
Other assets 113 42
Accounts payable 635 (4,049)
Accrued compensation (800) (4,522)
Accrued research and development expenses (58) (7,642)
Other current liabilities 121 (3,677)
Deferred revenue (203) (94,081)
Operating lease liabilities (809) (4,901)
Other long-term liabilities   1
Net cash used in operating activities (7,290) (45,243)
Investing activities    
Purchases of short-term investments (9,493) (7,885)
Proceeds from maturities and sales of short-term investments 3,700 17,200
Proceeds from sale of property and equipment   393
Net cash (used in) provided by investing activities (5,793) 9,708
Financing activities    
Proceeds from issuance of common stock through ATM facilities, net 8,656 1,496
Proceeds from sale of pre-funded warrants to purchase common stock in an underwritten registered direct offering or registered direct offering, net   14,843
Proceeds from employee stock awards   13
Principal payments on finance lease obligations   (250)
Other financing activities, net   (1)
Net cash provided by financing activities 8,656 16,101
Increase (decrease) in cash, cash equivalents and restricted cash (4,427) (19,434)
Cash, cash equivalents and restricted cash at beginning of period 8,482 25,176
Cash, cash equivalents and restricted cash at end of period 4,055 5,742
Non-cash financing activities    
Issuance of pre-funded warrants in connection with HCRx Amendment 1,672  
Accrued costs related to underwritten registered direct offering   25
Accrued costs related to ATM facility 118  
Supplemental cash flow disclosure    
Cash paid for interest 421 171
Cash paid for income taxes $ 1 $ 31

Source